Total Payments
$995.97
2024 Payments
$195.17
Companies
14
Transactions
34
Medicare Patients
13,288
Medicare Billing
$1.5M
Payment Breakdown by Category
Food & Beverage$806.03 (80.9%)
Education$189.94 (19.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $806.03 | 32 | 80.9% |
| Education | $189.94 | 2 | 19.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $229.35 | 4 | $0 (2023) |
| ABBVIE INC. | $199.46 | 9 | $0 (2024) |
| Allergan Inc. | $132.35 | 1 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $116.35 | 3 | $0 (2024) |
| Lilly USA, LLC | $81.84 | 5 | $0 (2023) |
| GENZYME CORPORATION | $70.51 | 3 | $0 (2024) |
| PFIZER INC. | $31.59 | 2 | $0 (2020) |
| VYNE Pharmaceuticals Inc. | $26.85 | 1 | $0 (2021) |
| Regeneron Healthcare Solutions, Inc. | $25.17 | 1 | $0 (2023) |
| LEO Pharma Inc. | $19.46 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $195.17 | 7 | GENZYME CORPORATION ($70.51) |
| 2023 | $305.09 | 11 | Janssen Biotech, Inc. ($114.69) |
| 2022 | $35.63 | 1 | E.R. Squibb & Sons, L.L.C. ($35.63) |
| 2021 | $51.56 | 2 | VYNE Pharmaceuticals Inc. ($26.85) |
| 2020 | $177.29 | 6 | Janssen Biotech, Inc. ($89.95) |
| 2019 | $65.31 | 4 | AbbVie, Inc. ($35.45) |
| 2018 | $33.57 | 2 | LEO Pharma Inc. ($19.46) |
| 2017 | $132.35 | 1 | Allergan Inc. ($132.35) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/24/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $32.65 | General |
| Category: IMMUNOLOGY | ||||||
| 10/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: Immunology | ||||||
| 09/18/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $46.03 | General |
| Category: Immunology | ||||||
| 08/08/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.54 | General |
| Category: Immunology | ||||||
| 06/27/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: Immunology | ||||||
| 05/16/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Dermatology | ||||||
| 02/01/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.25 | General |
| Category: IMMUNOLOGY | ||||||
| 11/16/2023 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Immunology | ||||||
| 10/16/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 08/17/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.17 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/25/2023 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Immunology | ||||||
| 06/27/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Immunology | ||||||
| 05/30/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: IMMUNOLOGY | ||||||
| 05/09/2023 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Immunology | ||||||
| 03/08/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $32.08 | General |
| Category: IMMUNOLOGY | ||||||
| 02/17/2023 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: Immunology | ||||||
| 01/23/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: IMMUNOLOGY | ||||||
| 01/19/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $34.69 | General |
| Category: Immunology | ||||||
| 11/11/2022 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $35.63 | General |
| Category: Immunology | ||||||
| 11/23/2021 | Janssen Biotech, Inc. | REMICADE (Biological), STELARA, SIMPONI ARIA | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: Immunology | ||||||
| 06/02/2021 | VYNE Pharmaceuticals Inc. | ZILXI (Drug) | Food and Beverage | In-kind items and services | $26.85 | General |
| Category: Treatment of Rosacea | ||||||
| 11/08/2020 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: Immunology | ||||||
| 11/03/2020 | AbbVie Inc. | SKYRIZI (Biological), HUMIRA | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/13/2020 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $89.95 | General |
| Category: Immunology | ||||||
| 08/18/2020 | Helsinn Therapeutics (U.S.), Inc. | VALCHLOR (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 3,627 | 7,685 | $1.6M | $381,718 |
| 2022 | 19 | 3,716 | 7,889 | $1.6M | $386,609 |
| 2021 | 18 | 3,199 | 7,342 | $1.6M | $384,914 |
| 2020 | 13 | 2,746 | 7,189 | $1.6M | $392,101 |
Total Patients
13,288
Total Services
30,105
Medicare Billing
$1.5M
Procedure Codes
68
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 2,329 | 5,201 | $1.2M | $270,814 | 22.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 272 | 502 | $156,514 | $45,113 | 28.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 158 | 211 | $45,576 | $16,760 | 36.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 165 | 236 | $36,580 | $8,368 | 22.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 59 | 59 | $18,644 | $6,876 | 36.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 101 | 112 | $21,952 | $6,400 | 29.2% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Office | 2023 | 148 | 163 | $22,320 | $4,800 | 21.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 137 | 831 | $11,634 | $4,313 | 37.1% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 37 | 39 | $9,594 | $3,629 | 37.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 51 | 86 | $9,030 | $3,300 | 36.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 38 | $8,373 | $2,406 | 28.7% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 36 | 62 | $13,330 | $1,892 | 14.2% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Office | 2023 | 17 | 45 | $9,225 | $1,846 | 20.0% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 15 | 18 | $8,568 | $1,717 | 20.0% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2023 | 30 | 38 | $8,930 | $1,379 | 15.4% |
| 11402 | Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 11 | 12 | $3,768 | $802.80 | 21.3% |
| 11105 | Punch biopsy, each additional skin growth | Office | 2023 | 11 | 17 | $2,057 | $737.64 | 35.9% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 15 | 15 | $2,037 | $565.24 | 27.7% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 2,308 | 5,158 | $1.2M | $269,061 | 22.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 194 | 327 | $100,260 | $29,965 | 29.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 129 | 185 | $39,960 | $14,152 | 35.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 147 | 206 | $43,638 | $12,865 | 29.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 126 | 148 | $29,008 | $9,097 | 31.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 158 | 241 | $37,355 | $8,247 | 22.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 69 | 154 | $16,170 | $6,004 | 37.1% |
About Dr. Catherine Barry, DO
Dr. Catherine Barry, DO is a Dermatopathology healthcare provider based in Charlottesville, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2007. The National Provider Identifier (NPI) number assigned to this provider is 1730382581.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Catherine Barry, DO has received a total of $995.97 in payments from pharmaceutical and medical device companies, with $195.17 received in 2024. These payments were reported across 34 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($806.03).
As a Medicare-enrolled provider, Barry has provided services to 13,288 Medicare beneficiaries, totaling 30,105 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatopathology
- Other Specialties Anatomic Pathology
- Location Charlottesville, VA
- Active Since 06/08/2007
- Last Updated 08/24/2015
- Taxonomy Code 207ZD0900X
- Entity Type Individual
- NPI Number 1730382581
Products in Payments
- TREMFYA (Drug) $204.64
- ACZONE (Drug) $132.35
- Sotyktu (Drug) $116.35
- DUPIXENT (Biological) $95.68
- SKYRIZI (Biological) $84.39
- TALTZ (Drug) $81.84
- RINVOQ (Biological) $64.73
- Humira (Biological) $35.45
- EUCRISA (Drug) $31.59
- ZILXI (Drug) $26.85
- REMICADE (Biological) $24.71
- FINACEA (Drug) $19.46
- Erivedge (Biological) $18.36
- COSENTYX (Drug) $17.73
- VALCHLOR (Drug) $15.45
- HUMIRA (Biological) $14.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatopathology Doctors in Charlottesville
Linglei Ma, Md, MD
Dermatopathology — Payments: $406.07
Dermatopathology $406.07
Brett Krasner, M.d, M.D
Dermatopathology — Payments: $235.34
Dermatopathology $235.34
Dr. David Rowe, Md, MD
Dermatopathology — Payments: $196.97
Dermatopathology $196.97
Ashley Craddock, Md, MD
Dermatopathology — Payments: $27.00
Dermatopathology $27.00
Mark Teague, M.d, M.D
Dermatopathology
Dermatopathology
Shyam Raghavan, M.d, M.D
Dermatopathology
Dermatopathology